Logo Image
News
Media
Peer ExchangeCase-Based Psych PerspectivesClinical Case CollectiveClinical Forum InsightsInsightsPeers & PerspectivesShortsSlideshowsVideos
Conferences
Conference CoverageConference Listing
Publication
Psychiatric Times
More
Job Board
CME/CE
Partners
Editorial
Resources
Between the LinesExpert PerspectivesClinical ConsultClinical ScalesInteractive ToolsLive EventsPartner PerspectivesQ&AQuizzesSeriesSpecial ReportsSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Publication
  • Job Board
  • CME/CE
  • Partners
  • Editorial
  • Resources
  • Subscribe
  • ADHD
  • Addiction & Substance Use
    • Behavioral Addictions
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Amphetamine Related Disorders
    • Substance Use Disorder
  • Alzheimer Disease & Dementia
  • Anxiety Disorders
    • Panic Disorder
  • Cannabis
  • Case Discussions
  • Comorbidity
  • Consultation-Liaison Psychiatry
    • COVID-19
  • Cultural Psychiatry
  • Drug Watch
  • Eating Disorders
  • Emergency Psychiatry
  • Ethics
  • Forensic Psychiatry
    • Munchausen Syndrome
    • Sexual Offenses
  • Integrative Psychiatry
  • Life Cycle Psychiatry
    • Postpartum Disorders
    • Geriatric Psychiatry
    • Child & Adolescent Psychiatry
  • Mental Health Awareness Month
  • Mood Disorders
    • Major Depressive Disorder
    • Bipolar Disorder
  • Neuromodulation
  • Neuropsychiatry
    • Cognition
    • Dementia
    • Autism
  • Obsessive-Compulsive Disorders
  • PTSD, Trauma & Stress Disorders
    • Disaster Psychiatry
    • Trauma And Violence
    • Traumatic Stress Disorders
  • Personality Disorders
    • Compulsive Personality Disorder
    • Dependent Personality Disorder
    • Dissociative Identity Disorder
    • Histrionic Personality Disorder
    • Schizoid Personality Disorder
    • Antisocial Personality Disorder
    • Borderline Personality
  • Psychedelics & Cannabis
  • Psychiatry & Society
    • Diversity, Equity, Inclusion
    • Climate Change
    • Media & Psychiatry
  • Psychopharmacology
  • Psychosomatics
    • Delirium
    • Metabolic Disorders
    • Somatoform Disorder
  • Psychotherapy
    • Cognitive Behavioral Therapy
  • Schizophrenia/Psychosis
    • Paranoid Schizophrenia
    • Psychotic Affective Disorders
    • Schizoaffective
    • Schizophrenia Psychotic Features
    • Schizotypal Personality Disorder
    • Catatonic Schizophrenia
  • Sleep-Wake Disorders
    • Narcolepsy
    • Nocturnal Paroxysmal Dystonia
    • Sleep Deprivation
    • Sleep Wake Transition
    • Circadian Rhythm Sleep Disorders
  • Special Populations
    • Sports Psychiatry
    • Pervasive Developmental Disorder
    • LGBTQ+
    • Gender Issues
    • Military Mental Health
  • Suicide
  • Tardive Dyskinesia
  • Technology & Psychiatry
    • Digital Therapeutics
    • Artificial Intelligence
Spotlight -
Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|
Major Depressive Disorder
Advertisement

Zoltan Sarnyai, MD, PhD

Advertisement

Dr Sarnyai is a neuroscientist and professor at James Cook University, Australia.

Articles by Zoltan Sarnyai, MD, PhD

Boosting Brain Health After COVID-19: A Convergence Solution

ByHarris A. Eyre, MD, PhD,Jessica Carson,Erin Smith,Helen Lavretsky, MD, MS,Charles F. Reynolds III, MD,Husseini K. Manji, MD,Walter D. Dawson, DPhil,Laura Booi, PhD,Mark Heinemeyer,Jeffrey L. Cummings, MD, ScD,Ernestine Fu, PhD,Eric A. Storch, PhD,William Hynes, DPhil,Eric J. Lenze, MD,Retsina Meyer, PhD,Ian Macrae, PhD,Antonella Santuccione Chadha, MD,Ryan Abbott, MD, JD, PhD,Sandra Bond Chapman, PhD,Ian Robertson, PhD,Carol Graham,Brisa S. Fernandes, MD, MSc, PhD,David G. Angeler, PhD,Adrienne Grzenda, MD, PhD,Agustin Ibañez, PhD,Zoltan Sarnyai, MD, PhD,Sofia Marcha,Michael Berk, MD, PhD,Patrick Brannelly
May 14th 2021

How can we face the current pandemic while addressing the brain health crisis?

Advertisement

Latest Updated Articles

  • Boosting Brain Health After COVID-19: A Convergence Solution
    Boosting Brain Health After COVID-19: A Convergence Solution

    May 14th 2021



Advertisement
Advertisement

Trending on Psychiatric Times

1

New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression

2

Nonpharmacological Augmentation of Ketamine, Neuroplasticity, and Behavioral Therapy

3

FDA Issues CRL for CTx-1301 for Treatment of ADHD

4

Suicide Risk Assessment in Patients Denying Suicidal Intent

5

Pregnancy & Tylenol: The Truth Behind the Mistaken Association

  • About
  • Advertise
  • Contact Us
  • Editorial
  • Terms and Conditions
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us